Jiayun Lin

500 total citations
29 papers, 358 citations indexed

About

Jiayun Lin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jiayun Lin has authored 29 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Jiayun Lin's work include Liver Disease and Transplantation (14 papers), Liver Disease Diagnosis and Treatment (13 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Jiayun Lin is often cited by papers focused on Liver Disease and Transplantation (14 papers), Liver Disease Diagnosis and Treatment (13 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Jiayun Lin collaborates with scholars based in China, Taiwan and United States. Jiayun Lin's co-authors include Chihao Zhang, Yiming Zhu, Meng Luo, Lei Zheng, Wensheng Deng, Meng Luo, Hsien‐Chie Cheng, Wen‐Hwa Chen, Xiaoliang Qi and Lei Zheng and has published in prestigious journals such as Frontiers in Immunology, Experimental Cell Research and Life Sciences.

In The Last Decade

Jiayun Lin

25 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayun Lin China 12 135 108 99 85 67 29 358
Zhengjun Liu China 10 121 0.9× 75 0.7× 69 0.7× 91 1.1× 101 1.5× 16 405
Jing Dong China 13 115 0.9× 236 2.2× 55 0.6× 245 2.9× 45 0.7× 57 524
Jeffrey Meier United States 8 109 0.8× 77 0.7× 89 0.9× 97 1.1× 66 1.0× 13 375
Yongjian Li China 10 79 0.6× 44 0.4× 48 0.5× 23 0.3× 26 0.4× 30 313
Giovanni Galati Italy 12 89 0.7× 287 2.7× 16 0.2× 165 1.9× 30 0.4× 44 509
Kewei Hu China 9 127 0.9× 56 0.5× 76 0.8× 56 0.7× 112 1.7× 16 444
Minoru Ogawa Japan 12 150 1.1× 122 1.1× 58 0.6× 23 0.3× 94 1.4× 28 411
Zhenhua Tu China 9 94 0.7× 193 1.8× 48 0.5× 209 2.5× 35 0.5× 13 463
Sandrine Vijgen Switzerland 8 65 0.5× 89 0.8× 29 0.3× 35 0.4× 44 0.7× 13 319

Countries citing papers authored by Jiayun Lin

Since Specialization
Citations

This map shows the geographic impact of Jiayun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayun Lin more than expected).

Fields of papers citing papers by Jiayun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayun Lin. The network helps show where Jiayun Lin may publish in the future.

Co-authorship network of co-authors of Jiayun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayun Lin. A scholar is included among the top collaborators of Jiayun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayun Lin. Jiayun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Zhenghao, Qiang Fan, Chihao Zhang, et al.. (2025). S‐Allyl‐Cysteine Ameliorates Cirrhotic Portal Hypertension by Enhancing Lymphangiogenesis via a VEGF ‐C‐Independent Manner. Liver International. 45(3). e70024–e70024. 2 indexed citations
3.
Zhao, Zhifeng, Qiang Fan, Chihao Zhang, et al.. (2024). Imperatorin attenuates CCl4-induced cirrhosis and portal hypertension by improving vascular remodeling and profibrogenic pathways. European Journal of Pharmacology. 980. 176833–176833. 3 indexed citations
4.
Zhang, Chihao, Wei Ni, Yiming Zhu, et al.. (2022). Construction and comprehensive analysis of a lncRNA–mRNA interactive network to reveal a potential lncRNA for hepatic encephalopathy development. Human Cell. 35(4). 1060–1070. 2 indexed citations
5.
Zhao, Zhifeng, Yanna Zhao, Wenjuan Xu, et al.. (2022). Salivary biomarkers-assisted ultrasound-based differentiation of malignant and benign thyroid nodules. Gland Surgery. 11(1). 196–206. 4 indexed citations
6.
Zhang, Chihao, et al.. (2022). Identification of significant modules and hub genes involved in hepatic encephalopathy using WGCNA. European journal of medical research. 27(1). 264–264. 5 indexed citations
7.
Zhang, Chihao, Jiayun Lin, Xiaochun Ni, et al.. (2021). Prognostic Value of Serum Osteoprotegerin Level in Patients With Hepatocellular Carcinoma Following Surgical Resection. Frontiers in Oncology. 11. 731989–731989. 6 indexed citations
8.
Wang, Xinxin, Haitao Gu, Kaichun Li, et al.. (2021). DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility. Life Sciences. 284. 119895–119895. 6 indexed citations
9.
Zhao, Zhifeng, Chihao Zhang, Jiayun Lin, et al.. (2021). COX-2/sEH Dual Inhibitor PTUPB Alleviates CCl4-Induced Liver Fibrosis and Portal Hypertension. Frontiers in Medicine. 8. 761517–761517. 8 indexed citations
10.
Zhu, Yiming, et al.. (2021). TRIM26 Induces Ferroptosis to Inhibit Hepatic Stellate Cell Activation and Mitigate Liver Fibrosis Through Mediating SLC7A11 Ubiquitination. Frontiers in Cell and Developmental Biology. 9. 644901–644901. 77 indexed citations
11.
Zhao, Zhifeng, Yiming Zhu, Xiaochun Ni, et al.. (2021). Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC. Cancer Cell International. 21(1). 517–517. 12 indexed citations
12.
Zheng, Lei, Zhifeng Zhao, Jiayun Lin, et al.. (2021). Telmisartan relieves liver fibrosis and portal hypertension by improving vascular remodeling and sinusoidal dysfunction. European Journal of Pharmacology. 915. 174713–174713. 11 indexed citations
13.
Xu, Xin, En Zhou, Jun Zheng, et al.. (2021). Prognostic and Predictive Value of m6A “Eraser” Related Gene Signature in Gastric Cancer. Frontiers in Oncology. 11. 631803–631803. 19 indexed citations
14.
Lin, Jiayun, Chihao Zhang, Lei Zheng, et al.. (2020). Assessment of a biofluid mechanics-based model for calculating portal pressure in canines. BMC Veterinary Research. 16(1). 308–308. 1 indexed citations
15.
Zheng, Lei, Chihao Zhang, Jiayun Lin, et al.. (2020). Comparative Effectiveness of Radiofrequency Ablation vs. Surgical Resection for Patients With Solitary Hepatocellular Carcinoma Smaller Than 5 cm. Frontiers in Oncology. 10. 399–399. 20 indexed citations
16.
Zhao, Zhifeng, Yeping Yu, Dan Xu, et al.. (2020). Prognostic value of the creatinine-albumin ratio in acute pancreatitis debridement. BMC Surgery. 20(1). 322–322. 23 indexed citations
17.
18.
Zhu, Yiming, Wensheng Deng, Jiayun Lin, et al.. (2018). Effects of NLRP6 on the proliferation and activation of human hepatic stellate cells. Experimental Cell Research. 370(2). 383–388. 21 indexed citations
19.
Deng, Wensheng, Yiming Zhu, Jiayun Lin, et al.. (2017). Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis. Prostaglandins & Other Lipid Mediators. 131. 67–74. 19 indexed citations
20.
Zhang, Chihao, Gui L, Jiayun Lin, et al.. (2017). Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats. Clinics and Research in Hepatology and Gastroenterology. 42(2). 118–125. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengjun Liu Breakdown of academic impact, for papers by Jing Dong Breakdown of academic impact, for papers by Jeffrey Meier Breakdown of academic impact, for papers by Yongjian Li Breakdown of academic impact, for papers by Giovanni Galati Breakdown of academic impact, for papers by Kewei Hu Breakdown of academic impact, for papers by Minoru Ogawa Breakdown of academic impact, for papers by Zhenhua Tu Breakdown of academic impact, for papers by Sandrine Vijgen
Rankless by CCL
2026